In vitro studies of ferric carboxymaltose on placental permeability using the dual perfusion model of human placenta

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 6, 2010, Pages 354-361

  Malek, Antoine ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FERRIC CARBOXYMALTOSE; FERRIC ION; IRON; MALTOSE; TRANSFERRIN;

ARTERY; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; METHODOLOGY; PERFUSION; PERMEABILITY; PHYSIOLOGY; PLACENTA; PREGNANCY; PRENATAL DEVELOPMENT; VEIN;

ARTERIES; FEMALE; FERRIC COMPOUNDS; HUMANS; IRON; IRON RADIOISOTOPES; MALTOSE; PERFUSION; PERMEABILITY; PLACENTA; PREGNANCY; TRANSFERRIN; VEINS;

EID: 77956861140     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296300     Document Type: Article

References (32)

1. Dallman PR. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr. 1986; 6: 13-40.
2. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000; 105: E51 [cited: 4 April 2000]. Available from: www. pediatrics.org/cgi/content/full/105/4/e51
3. Walter T, De Andraca I, Chadud P, Perales CG. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics. 1989; 84: 7-17.
4. Felt BT, Lozoff B. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr. 1996; 126: 693-701.
5. Yip R. Iron. In: Bowman B, Russell RM, editors. Present knowledge in nutrition. 8th ed. Washington DC: ILSI Press; 2001. p. 311-318.
6. Perry GS, Yip R, Zyrkowski C. Nutritional risk factors among low-income pregnant US women: The Centers for Disease Control and Prevention (CDC) Pregnancy Nutrition Surveillance System, 1979-1993. Sem Perinatol. 1995; 19: 211-221.
7. Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr. 1994; 59(Suppl): 492S-501S.
8. Institute of Medicine, Subcommittee on Nutritional Status and Weight Gain during Pregnancy. Nutrition during pregnancy. Washington DC: National Academy Press; 1990.
9. Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005; 81: 1218S-1222S.
10. Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. JNutr. 2003; 133(5 Suppl 2): 1700S-1708S.
11. Bernotti S, Seidman E, Sinnett D, Brunet S, Dionne S, Del-vin E, Levy E. Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/as-corbate-mediated lipid peroxidation. Am J Physiol Gastrointest Liver Physiol. 2003; 285: G898-906.
12. Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001; 15: 1989-1999.
13. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium, and leucine. Am J Obstet Gynecol. 1972; 114: 822-828.
14. Di Santo S, Malek A, Sager R, Andres AC, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limites to 7-24 hours. Placenta. 2003; 24: 882-894.
15. Malek A, Bersinger NA, Di Santo S, Mueller MD, Sager R, Schneider H, et al. C-reactive protein production in term human placental tissue. Placenta. 2006; 27: 619-625.
16. Malek A, Sager R, Altermatt HJ, Gaeng D, Leiser R, Schneider H. Glucose consumption and lactate production of human placental tissue under different conditions of in vitro incubation. J Soc Gynecol Investig. 1996; 3: 113-120.
17. Malek A, Sager R, Lang AB, Schneider H. Protein transport across the in vitro perfused human placenta. Am J Reprod Immunol. 1997; 38: 263-271.
18. Wier PJ, Miller RK. Oxygen transfer as an indicator of perfusion variability in the isolated human placental lobule. Contrib Gynecol Obstet. 1985; 13: 127-131.
19. Mose T, Mortensen GK, Hedegaard M, Knudsen LE. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol. 2007; 23: 83-91.
20. Malek A, Leiser R. Influence of the magnesium aspartate hydrochloride administration to the maternal circuit on the aspartate concentration of the fetal circuit under in vitro perfusion of human placenta. Eur J Obstet Gynecol Reprod Biol. 2009; 142: 12-17.
21. Schneider H, Dancis J. In vitro human placental perfusion of human placenta. Trophoblast Res. 1987; 2: 597-605.
22. Bajoria R, Fisk NM. Permeability of human placenta and fetal membranes to thyrotropin-stimulating hormone in vitro. Pediatr Res. 1998; 43: 621-628.
23. Schmolling J, Brunken M, Richter O, Ulrich U, Schmidt S, Krebs D. Photoradiation of perfused placental tissue-a suitable in vitro model for photodynamic therapy? Arch Gynecol Obstet. 2001; 265: 199-203.
24. Brodie BB. The estimation of antipyrine in biological materials. J Biol Chem. 1949; 179: 25-29.
25. Malek A, Sager R, Willi A, Müller J, Hänggi W, Leiser R, et al. Production of protein hormones by cultured trophoblast cells isolated from term and early placentae. Am J Reprod Immunol. 2000; 43: 278-284.
26. Malek A, Willi A, Müller J, Sager R, Hänggi W, Bersinger N. Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy. J Assist Reprod Genet. 2001; 18: 299-304.
27. Malek A, Sager R, Zakher A, Schneider H. Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta. Am J Obstet Gynecol. 1995; 173: 760-767.
28. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996; 36: 248-255.
29. Malek A, Leiser R. Influence of the magnesium aspartate hydrochloride administration to the maternal circuit on the aspartate concentration of the fetal circuit under in vitro perfusion of human placenta. Eur J Obstet Gynecol Reprod Biol. 2009; 142: 12-17.
30. Myren M, Mose T, Mathiesen L, Knudsen LE. The human placenta-an alternative for studying foetal exposure. Toxicol In Vitro. 2007; 21: 1332-1340.
31. Crichton RR, Danielson BG, Geisser P. Iron therapy with special emphasis on intravenous administration. 4th ed. Bremen (Germany): UNI-MED; 2008.
32. Malek A, Sager R, Zakher A, Schneider H. Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta. Am J Obstet Gynecol. 1995; 173: 760-767.